- Home
- AUPH vs JFR Comparison
AUPH vs JFR Comparison
Compare AUPH & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- JFR
- Stock Information
- Founded
- AUPH 1993
- JFR 2004
- Country
- AUPH Canada
- JFR United States
- Employees
- AUPH N/A
- JFR N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- JFR Trusts Except Educational Religious and Charitable
- Sector
- AUPH Health Care
- JFR Finance
- Exchange
- AUPH Nasdaq
- JFR Nasdaq
- Market Cap
- AUPH 1.4B
- JFR 1.1B
- IPO Year
- AUPH 1999
- JFR N/A
- Fundamental
- Price
- AUPH $11.47
- JFR $8.11
- Analyst Decision
- AUPH Strong Buy
- JFR
- Analyst Count
- AUPH 2
- JFR 0
- Target Price
- AUPH $13.00
- JFR N/A
- AVG Volume (30 Days)
- AUPH 1.9M
- JFR 621.7K
- Earning Date
- AUPH 11-06-2025
- JFR 01-01-0001
- Dividend Yield
- AUPH N/A
- JFR 11.31%
- EPS Growth
- AUPH N/A
- JFR N/A
- EPS
- AUPH 0.42
- JFR N/A
- Revenue
- AUPH $260,111,000.00
- JFR N/A
- Revenue This Year
- AUPH $17.33
- JFR N/A
- Revenue Next Year
- AUPH $14.31
- JFR N/A
- P/E Ratio
- AUPH $27.48
- JFR N/A
- Revenue Growth
- AUPH 25.59
- JFR N/A
- 52 Week Low
- AUPH $6.55
- JFR $7.61
- 52 Week High
- AUPH $13.54
- JFR $8.82
- Technical
- Relative Strength Index (RSI)
- AUPH 47.42
- JFR 36.34
- Support Level
- AUPH $11.08
- JFR $8.03
- Resistance Level
- AUPH $11.87
- JFR $8.19
- Average True Range (ATR)
- AUPH 0.62
- JFR 0.07
- MACD
- AUPH -0.14
- JFR -0.00
- Stochastic Oscillator
- AUPH 44.06
- JFR 37.50
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.